Post-authorization Safety Study Evaluation of Cardiovascular Events in Users of Mirabegron and Other Treatments for Overactive Bladder

30/11/2016
02/07/2024
EU PAS number:
EUPAS16282
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

178-CL-114_Protocol Version 9.0_For EnCepp Reg

English (1.17 MB - PDF) View document
Updated protocol

178-cl-114-clp-10-reissue-v11-en-final-02

First published: 22/02/2024
English (2.09 MB - PDF) View document
Study results
Study results

178-cl-114-clgr-disc01-en-final-02

English (745.17 KB - PDF) View document
Study report
Other information